Endpoint definition
↥| Name | DRUGADVERS_APLAST_ANAEM | 
|---|---|
| Long name | Drug-induced aplastic anaemia | 
| Hospital Discharge registry | ICD-10: D611 | 
| Level in the ICD-hierarchy | C | 
| First defined in version | DF5 | 
| Name | DRUGADVERS_APLAST_ANAEM | 
|---|---|
| Long name | Drug-induced aplastic anaemia | 
| Hospital Discharge registry | ICD-10: D611 | 
| Level in the ICD-hierarchy | C | 
| First defined in version | DF5 | 
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 20 | 12 | 8 | 
| Unadjusted prevalence (%) | 0.01 | 0.01 | 0.01 | 
| Mean age at first event (years) | 59.21 | 58.11 | 60.85 | 
| Case fatality at 5-years (%) | 40.00 | 41.67 | 37.50 | 
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.0 | 
| Recurrence at 6 months (%) | 15.00 | 25.00 | - | 
						 before Drug-induced aplastic anaemia
						
						 after Drug-induced aplastic anaemia
					
Loading survival analyses plot…
Loading survival analyses table…